Cholesterol 24S-Hydroxylase overexpression inhibits the liver X receptor (LXR) pathway by activating small guanosine triphosphate-binding proteins (sGTPases) in neuronal cells

The neuronal-specific cholesterol 24S-hydroxylase (CYP46A1) is important for brain cholesterol elimination. Cyp46a1 null mice exhibit severe deficiencies in learning and hippocampal long-term potentiation, suggested to be caused by a decrease in isoprenoid intermediates of the mevalonate pathway. Conversely, transgenic mice overexpressing CYP46A1 show an improved cognitive function. These results raised the question of whether CYP46A1 expression can modulate the activity of proteins that are crucial for neuronal function, namely of isoprenylated small guanosine triphosphate-binding proteins (sGTPases). Our results show that CYP46A1 overexpression in SH-SY5Y neuroblastoma cells and in primary cultures of rat cortical neurons leads to an increase in 3-hydroxy-3-methyl-glutaryl-CoA reductase activity and to an overall increase in membrane levels of RhoA, Rac1, Cdc42 and Rab8. This increase is accompanied by a specific increase in RhoA activation. Interestingly, treatment with lovastatin or a geranylgeranyltransferase-I inhibitor abolished the CYP46A1 effect. The CYP46A1-mediated increase in sGTPases membrane abundance was confirmed in vivo, in membrane fractions obtained from transgenic mice overexpressing this enzyme. Moreover, CYP46A1 overexpression leads to a decrease in the liver X receptor (LXR) transcriptional activity and in the mRNA levels of ATP-binding cassette transporter 1, sub-family A, member 1 and apolipoprotein E. This effect was abolished by inhibition of prenylation or by co-transfection of a RhoA dominant-negative mutant. Our results suggest a novel regulatory axis in neurons; under conditions of membrane cholesterol reduction by increased CYP46A1 expression, neurons increase isoprenoid synthesis and sGTPase prenylation. This leads to a reduction in LXR activity, and consequently to a decrease in the expression of LXR target genes.

���Papel dos recetores purin��rgicos no crescimento e temodela����o do tecido cavernoso���

A adenosina �� um nucle��sido ub��quo envolvido na regula����o de controlo do t��nus vascular do tecido cavernoso, desempenhando um papel importante na fisiopatologia da Disfun����o Er��til (DE) resistente aos f��rmacos relaxantes musculares cl��ssicos. Apesar da import��ncia comprovada dos recetores da adenosina na fisiopatologia da DE no homem, pouca informa����o �� conhecida no que diz respeito �� express��o e localiza����o dos recetores purin��rgicos no Tecido Cavernoso de Ratazana (TCR). Neste trabalho avaliou-se o fen��tipo dos recetores purin��rgicos respons��veis pela regula����o do t��nus do tecido er��til de ratazana por imunofluoresc��ncia indireta aplicada �� microscopia confocal em co-culturas de c��lulas endoteliais e musculares lisas do TCR. Para al��m da caracteriza����o imunofenot��pica, desenvolveu-se uma t��cnica que permite diferenciar funcionalmente em tempo real (por microscopia confocal funcional) c��lulas musculares lisas e c��lulas endoteliais isoladas de TCR em co-cultura marcadas com a sonda fluorescente Fluo-4NW. Esta t��cnica permite distinguir cada um dos subtipos celulares mediante o padr��o e a magnitude das oscila����es dos n��veis intracelulares de Ca2+ ([Ca2+]i) em resposta ao ATP (agonista P2) e �� fenilefrina (PE, agonista ��-adren��rgico). Nas c��lulas musculares lisas, observou-se uma resposta mais acentuada ao agonista ��-adren��rgico, PE, e uma resposta menos significativa ao ATP. O contr��rio foi observado relativamente ��s c��lulas endoteliais. A incuba����o das c��lulas musculares lisas e endoteliais com ATP (300 ��M) causou um aumento dos n��veis de [Ca2+]i. O efeito do ATP (300 ��M) parece envolver a ativa����o de recetores dos subtipos P2X1 e P2X3 sens��veis ao bloqueio com NF023 (3��M) e A317491 (100 nM), respetivamente. J�� o aumento dos n��veis [Ca2+]i produzido pelo ADP (300 ��M) parece envolver a ativa����o de recetores P2Y1, P2Y12 e P2Y13 mediante o antagonismo produzido pelos antagonistas MRS 2179 (0,3��M), AR-C66096 (0,1 ��M) e MRS 2211 (10��M), respetivamente. Os dois tipos celulares expressam imunorreatividade contra recetores A2A, A2B, P2X1, P2X3, P2Y1, P2Y12 e P2Y13.

Bradykinin-induced Ca2+ signaling in human subcutaneous fibroblasts involves ATP release via hemichannels leading to P2Y12 receptors activation

Background: Chronic musculoskeletal pain involves connective tissue remodeling triggered by inflammatory mediators, such as bradykinin. Fibroblast cells signaling involve changes in intracellular Ca2+ ([Ca2+]i). ATP has been related to connective tissue mechanotransduction, remodeling and chronic inflammatory pain, via P2 purinoceptors activation. Here, we investigated the involvement of ATP in bradykinin-induced Ca2+ signals in human subcutaneous fibroblasts. Results: Bradykinin, via B2 receptors, caused an abrupt rise in [Ca2+]i to a peak that declined to a plateau, which concentration remained constant until washout. The plateau phase was absent in Ca2+-free medium; [Ca2+]i signal was substantially reduced after depleting intracellular Ca2+ stores with thapsigargin. Extracellular ATP inactivation with apyrase decreased the [Ca2+]i plateau. Human subcutaneous fibroblasts respond to bradykinin by releasing ATP via connexin and pannexin hemichannels, since blockade of connexins, with 2- octanol or carbenoxolone, and pannexin-1, with 10Panx, attenuated bradykinin-induced [Ca2+]i plateau, whereas inhibitors of vesicular exocytosis, such as brefeldin A and bafilomycin A1, were inactive. The kinetics of extracellular ATP catabolism favors ADP accumulation in human fibroblast cultures. Inhibition of ectonucleotidase activity and, thus, ADP formation from released ATP with POM-1 or by Mg2+ removal from media reduced bradykinin-induced [Ca2+]i plateau. Selective blockade of the ADP-sensitive P2Y12 receptor with AR-C66096 attenuated bradykinin [Ca2+]i plateau, whereas the P2Y1 and P2Y13 receptor antagonists, respectively MRS 2179 and MRS 2211, were inactive. Human fibroblasts exhibited immunoreactivity against connexin-43, pannexin-1 and P2Y12 receptor. Conclusions: Bradykinin induces ATP release from human subcutaneous fibroblasts via connexin and pannexin-1-containing hemichannels leading to [Ca2+]i mobilization through the cooperation of B2 and P2Y12 receptors.

Expanding our therapeutic options: ��-blockers for colon cancer?

Supported by U. Porto/Santander Totta (IJUP) (PP-IJUP2011-320)

Broad-temperature range spectroscopy of the two-centre modular redox metalloprotein Desulfovibrio desulfuricans desulfoferrodoxin

Dalton Trans., 2003, 3328-3338

Molybdenum-containing proteins from Sulphate Reducing Bacteria: studying proteins with novel cofactors and revealing new features of old enzymes

Disserta����o apresentada para a obten����o do Grau de Doutor em Bioqu��mica, especialidade de Bioqu��mica-F��sica pela Universidade Nova de Lisboa, Faculdade de Ci��ncias e Tecnologia

Spectroscopic Studies and Characterization of a Novel Electron-Transfer Chain

A novel two-component enzyme system from Escherichia coli involving a flavorubredoxin (FlRd) and its reductase was studied in terms of spectroscopic, redox, and biochemical properties of its constituents. FlRd contains one FMN and one rubredoxin (Rd) center per monomer. To assess the role of the Rd domain, FlRd and a truncated form lacking the Rd domain (FlRd��Rd), were characterized. FlRd contains 2.9 ( 0.5 iron atoms/subunit, whereas FlRd��Rd contains 2.1 ( 0.6 iron atoms/subunit. While for FlRd one iron atom corresponds to the Rd center, the other two irons, also present in FlRd��Rd, are most probably due to a di-iron site. Redox titrations of FlRd using EPR and visible spectroscopies allowed us to determine that the Rd site has a reduction potential of -140 ( 15 mV, whereas the FMN undergoes reduction via a red-semiquinone, at -140 ( 15 mV (Flox/Flsq) and -180 ( 15 mV (Flsq/Flred), at pH 7.6. The Rd site has the lowest potential ever reported for a Rd center, which may be correlated with specific amino acid substitutions close to both cysteine clusters. The gene adjacent to that encoding FlRd was found to code for an FAD-containing protein, (flavo)rubredoxin reductase (FlRd-reductase), which is capable of mediating electron transfer from NADH to DesulfoVibrio gigas Rd as well as to E. coli FlRd. Furthermore, electron donation was found to proceed through the Rd domain of FlRd as the Rd-truncated protein does not react with FlRd-reductase. In vitro, this pathway links NADH oxidation with dioxygen reduction. The possible function of this chain is discussed considering the presence of FlRd homologues in all known genomes of anaerobes and facultative aerobes.

Proteomic analysis of the influence of the adipocyte secretome on Glioma Gl261 cells

Glioma is the most frequent form of malignant brain tumor in the adults and childhood. There is a global tendency toward a higher incidence of gliomas in highly developed and industrialized countries. Simultaneously obesity is reaching epidemic proportions in such developed countries. It has been highly accepted that obesity may play an important role in the biology of several types of cancer. We have developed an in vitro method for the understanding of the influence of obesity on glioma mouse cells (Gl261). 3T3-L1 mouse pre-adipocytes were induced to the maturity. The conditioned medium was harvested and used into the Gl261 cultures. Using two-dimension electrophoresis it was analyzed the proteome content of Gl261 in the presence of conditioned medium (CGl) and in its absence (NCGl). The differently expressed spots were collected and analyzed by means of mass spectroscopy (MALDI-TOF-MS). Significantly expression pattern changes were observed in eleven proteins and enzymes. RFC1, KIF5C, ANXA2, N-RAP, RACK1 and citrate synthase were overexpressed or only present in the CGl. Contrariwise, STI1, hnRNPs and phosphoglycerate kinase 1 were significantly underexpressed in CGl. Aldose reductase and carbonic anhydrase were expressed only in NCGl. Our results show that obesity remodels the physiological and metabolic behavior of glioma cancer cells. Also, proteins found differently expressed are implicated in several signaling pathways that control matrix remodeling, proliferation, progression, migration and invasion. In general our results support the idea that obesity may increase glioma malignancy, however, some interesting paradox finding were also reported and discussed.

Methemoglobinemia associated with loxoscelism

In twenty five patients who presented the cutaneous form of loxoscelism, serum haptoglobin and lactic dehydrogenase, erythrocyte glucose-6-phosphate dehydrogenase, glutathione reductase, glutathione peroxidase, methemoglobin, bilirubin and reticulocytes were investigated after bite. No hemolysis was detected but an increase in methemoglobin was found in 54% of the cases; in 7% it was between 1.1% and 2%, in 27% it ranged from 2.1% to 4%, and in 20% from 4.1% to 8%. Blood samples of a normal, blood group 0 individual and of a patient who exhibited methemoglobinemia after Loxosceles bite were incubated separately with antisera against Loxosceles gaucho, Crotalus terrificus, Bothrops jararaca, with Loxosceles gaucho venom and 0.3% phenol. No methemoglobin was found after 1, 4,8 and 15 days in both sets of samples. At the 25th day all the samples, including the controls, exhibited similar methemoglobin reductase decrease. The data suggest that the methemoglobinemia which occurs in 50% of the patients probably arises from in vivo venom metabolism, inasmuch as the crude venom does not induce methemoglobinemia.

Caracteriza����o da fun����o do mon��xido de azoto e glutationo hep��ticos na sensabilidade perif��rica �� insulina

xi RESUMO A ac����o da insulina no m��sculo esquel��tico depende de um reflexo parassimp��tico hep��tico que conduz �� liberta����o de uma subst��ncia hep��tica sensibilizadora da insulina, designada por HISS, respons��vel por cerca de 55% do efeito hipoglicemiante da insulina. A ac����o da HISS �� finamente regulada pelo mon��xido de azoto (NO) hep��tico e pelo estado prandial, aumentando no per��odo p��s-prandial imediato e diminuindo progressivamente com as horas de jejum. A secre����o da HISS pode ser inibida cir��rgica ou farmacologicamente, quer por desnerva����o selectiva do plexo anterior hep��tico, quer por administra����o de atropina, quer por inibi����o do sintase do NO (NOS) hep��tico. O objectivo geral do trabalho apresentado nesta disserta����o foi a caracteriza����o da via de transdu����o de sinal que conduz �� liberta����o da HISS. O modelo utilizado neste estudo foi o rato Wistar. A sensibilidade �� insulina foi avaliada atrav��s do teste r��pido de sensibilidade �� insulina (RIST). A primeira hip��tese de trabalho testada foi que a sequ��ncia de eventos que conduzem �� secre����o da HISS inicia-se com a activa����o do sistema parassimp��tico hep��tico seguida de activa����o do NOS hep��tico com subsequente produ����o de NO e activa����o do guanilato ciclase (GC). Observou-se que a administra����o de um dador de NO reverteu a resist��ncia �� insulina induzida, quer por inibi����o do NOS hep��tico, quer por antagonismo dos receptores muscar��nicos com atropina. Em contraste, a resist��ncia �� insulina produzida por inibi����o do NOS hep��tico n��o foi revertida por administra����o intraportal de acetilcolina (ACh). Constatou-se que a inibi����o do GC hep��tico diminuiu a sensibilidade �� insulina. Estes resultados sugerem que: a ACh libertada no f��gado induz a s��ntese de NO hep��tico que conduz �� liberta����o da HISS, que por sua vez �� modulada pelo GC hep��tico. A liberta����o da HISS em resposta �� insulina �� regulada pelo estado prandial. Uma vez que os n��veis hep��ticos de glutationo (GSH) se encontram, tal como a HISS, diminu��dos no estado de jejum e aumentados ap��s a ingest��o de uma refei����o, testou-se a hip��tese de que o GSH hep��tico est�� envolvido na secre����o da HISS. Observou-se que a deple����o do GSH hep��tico induziu resist��ncia �� insulina, compar��vel �� obtida ap��s inibi����o do NOS hep��tico. Estes resultados suportam a hip��tese de que o GSH hep��tico desempenha um papel cr��tico na ac����o perif��rica da insulina. Considerando que, no estado de jejum, tanto os n��veis de GSH hep��tico como os n��veis de NO hep��tico s��o baixos, testou-se a hip��tese de que a co-administra����o intraportal de um dador de GSH e de um dador de NO promove um aumento da sensibilidade �� insulina no estado de jejum, devido ao restabelecimento do mecanismo da HISS. Observou-se que a administra����o sequencial de dadores de GSH e de NO no f��gado provocou um aumento na sensibilidade �� insulina, dependente da dose de dador de GSH administrada. Concluiu-se portanto que ambos, GSH e NO, s��o essenciais para que o mecanismo da HISS esteja completamente funcional. O GSH e o NO reagem para formar um S-nitrosotiol, o S-nitrosoglutationo (GSNO). Os resultados supra-mencionados conduziram �� formula����o da hip��tese de que a secre����o/ac����o da HISS depende da forma����o de GSNO. Observou-se que a administra����o intravenosa de S-nitrosoti��is (RSNOs) aumentou a sensibilidade �� insulina, em animais submetidos a um per��odo de jejum, ao contr��rio da administra����o intraportal destes f��rmacos, o que RSNOs t��m uma ac����o perif��rica, mas n��o hep��tica, na sensibilidade �� insulina. Os resultados obtidos conduziram �� reformula����o da hip��tese da HISS, sugerindo que a ingest��o de uma refei����o activa os nervos parassimp��ticos hep��ticos levando �� liberta����o de ACh no f��gado que, por sua vez activa o NOS. Simultaneamente, ocorre um aumento dos n��veis de GSH hep��tico que reage com o NO hep��tico para formar um composto nitrosado, o GSNO. Este composto mimetiza a ac����o hipoglicemiante da HISS no m��sculo esquel��tico. SUMMARY Insulin action at the skeletal muscle depends on a hepatic parasympathetic reflex that promotes the release of a hepatic insulin sensitizing substance (HISS) from the liver, which contributes 55% to total insulin action. HISS action is modulated by hepatic nitric oxide (NO) and also by the prandial status so as to, in the immediate ostprandial state, HISS action is maximal, decreasing with the duration of fasting. HISS secretion may be inhibited by interruption of the hepatic parasympathetic reflex, achieved either by surgical denervation of the liver or by cholinergic blockade with atropine, or by prevention of hepatic NO release, using NO synthase (NOS) antagonists. The main objective of this work was to characterize the signal transduction pathways that lead to HISS secretion by the liver. Wistar rats were used and insulin sensitivity was evaluated using the rapid insulin sensitivity test (RIST). The first hypothesis tested was that the sequence of events that lead to HISS secretion starts with an increase in the hepatic parasympathetic tone, followed by the activation of hepatic NOS and subsequent triggering of guanylate cyclase (GC). We observed that insulin resistance produced either by muscarinic receptor antagonism with atropine or by hepatic NOS inhibition was reversed by the intraportal administration of an NO donor. In contrast, intraportal acetylcholine (ACh) did not restore insulin sensitivity after NOS inhibition. We also observed that GC inhibition lead to a decrease in insulin sensitivity.These results suggest that the release of ACh in the liver activates hepatic NO synthesis in order to allow HISS secretion, through a signaling pathway modulated by GC. HISS release in response to insulin is controlled by the prandial status. The second hypothesis tested was that glutathione (GSH) is involved in HISS secretion since the hepatic levels of GSH are, like HISS action, decreased in the fasted state and increased after ingestion of a meal. We observed that hepatic GSH depletion led to insulin resistance of the same magnitude of that observed after inhibition of hepatic NOS. These results support the hypothesis that hepatic GSH is crucial in peripheral insulin action. Since, in the fasted state, both hepatic GSH and NO levels are low, we tested the hypothesis that intraportal o-administration of a GSH donor and an NO donor enhances insulin sensitivity in fasted Wistar rats, by restoring HISS secretion. We observed that GSH and NO increased insulin sensitivity in a GSH dose-dependent manner. We concluded that HISS secretion requires elevated levels of both GSH and NO in the liver. GSH and NO react to form a S-nitrosothiol, S-nitrosoglutathione (GSNO). The last hypothesis tested in this work was that HISS secretion/ action depends on the formation of GSNO. We observed that intravenous administration of -nitrosothiols (RSNOs) increased insulin sensitivity in animals fasted for 24 h, in contrast with the intraportal administration of the drug. This result suggests that RSNOs enhanced insulin sensitivity through a peripheral, and not hepatic, mechanism. The results obtained led to a restructuring of the HISS hypothesis, suggesting that the ingestion of a meal triggers the hepatic parasympathetic nerves, leading to the release of Ach in the liver, which in turn activates NOS. Simultaneously, hepatic GSH levels increase and react with NO to form a nitrosated compound, GSNO. S-nitrosoglutathione mimics HISS hypoglycaemic action at the skeletal muscle.

Crystallographic and biochemical studies on dissimilatory sulfite reductases

Thesis dissertation presented to obtain a PhD degree in Biochemistry at Instituto de Tecnologia Qu��mica e Biol��gica, Universidade Nova de Lisboa

Avalia����o funcional e farmacol��gica do corpo carot��deo do rato no envelhecimento

Resumo: O corpo carot��deo gera o quimiorreflexo �� hipoxia, tendo por objectivo principal a homeostase dos gases do sangue. Esta tese testou a hip��tese da fun����o destes quimiossensores n��o se deteriorar ao longo da idade. In vivo, em ratos anestesiados, foram estudados os efeitos da idade nas respostas cardiorespirat��rias a dois tipos de est��mulos diferentes: a isquemia carot��dea e a manipula����o farmacol��gica de dois neurotransmissores com efeitos opostos nos quimiorreceptores, a adenosina e a dopamina. O modelo de isquemia carot��dea corresponde �� oclus��o bilateral da art��ria car��tida comum, durante per��odos de 5 a 15 s, o que determina um efeito excitat��rio na ventila����o que �� abolido pela sec����o bilateral dos nervos do seio carot��deo. No estudo farmacol��gico foram analisadas as respostas cardio-respirat��rias �� adenosina e �� dopamina ex��genas na presen��a e na aus��ncia de antagonistas selectivos para os receptores A2A e D2, respectivamente. In vitro, no corpo carot��deo, foi quantificado o efeito de diferentes concentra����es de oxig��nio no conte��do do segundo mensageiro comum �� activa����o dos receptores A2A e D2, o cAMP. Em conjunto, estes resultados demonstraram que no rato o controlo da ventila����o pelo corpo carot��deo se mant��m inalterado ao longo da idade.--------------------- ABSTRACT: The carotid body initiates reflexes aimed principally at the homeostatic maintenance of blood gas tensions. This thesis tested the hypothesis of the function of these quimiossensores not deteriorate through age. In vivo, in anesthetized rats, we studied the effects of age on cardiorespiratory responses to two different types of stimuli: carotid ischemia and pharmacological manipulation of neurotransmitters with two opposite effects on chemoreceptors, adenosine and dopamine. The model of carotid ischemia corresponded to bilateral occlusion of common carotid artery, during periods of 5 to 15 s, which determines an excitatory effect on ventilation that is abolished by bilateral section of carotid sinus nerve. The pharmacological study analyzed the cardiorespiratory responses to exogenous adenosine and dopamine in the presence and absence of selective antagonists for the A2A and D2 receptors, respectively. In vitro, at the carotid body, it was quantified the effect of different concentrations of oxygen in the content of the common second messenger for the activation of A2A and D2 receptors, the cAMP. Together, these results showed that in rats the control of ventilation by carotid body remains unchanged through age.

Snakebites by Bothrops spp in children in Campinas, S��o Paulo, Brazil

From January, 1984 to March, 1999, 73 children under 15 y old (ages 1-14 y, median 9 y) were admitted after being bitten by snakes of the genus Bothrops. Twenty-six percent of the children were classified as mild envenoming, 50.7% as moderate envenoming and 20.6% as severe envenoming. Two patients (2.7%) showed no signs of envenoming. Most of the patients presented local manifestations, mainly edema (94.5%), pain (94.5%) ecchymosis (73.9%) and blisters (11%). Local and/or systemic bleeding was observed in 28.8% of the patients. Before antivenom (AV) administration, blood coagulation disorders were observed in 60.7% (incoagulable blood in 39.3%) of the 56 children that received AV only in our hospital. AV early reactions, most of which were considered mild, were observed in 44.6% of these cases (in 15/30 patients not pretreated and in 10/26 patients pretreated with hydrocortisone and histamine H1 and H2 antagonists). The main clinical complications observed were local infection (15.1%), compartment syndrome (4.1%), gangrene (1.4%) and acute renal failure (1.4%). No deaths were recorded. There were no significant differences with regard to severity of envenoming versus the frequency of blood coagulation disorders among the three categories of envenoming (p = 0.75) or in the frequency of patients with AV early reactions between the groups that were and were not pretreated (p = 0.55). The frequency of local infection was significantly greater in severe cases (p < 0.001). Patients admitted more than 6 h after the bite had a higher risk of developing severe envenoming (p = 0.04).

Snakebites by Crotalus durissus ssp in children in Campinas, S��o Paulo, Brazil

From January, 1984 to March, 1999, 31 children under 15 y old (ages 1-14 y, median 8 y) were admitted after being bitten by rattlesnakes (Crotalus durissus ssp). One patient was classified as "dry-bite", 3 as mild envenoming, 9 as moderate envenoming and 18 as severe envenoming. Most patients had neuromuscular manifestations, such as palpebral ptosis (27/31), myalgia (23/31) and weakness (20/31). Laboratory tests suggesting rhabdomyolysis included an increase in total blood creatine kinase (CK, 28/29) and lactate dehydrogenase (LDH, 25/25) levels and myoglobinuria (14/15). The main local signs and symptoms were slight edema (20/31) and erythema (19/31). Before antivenom (AV) administration, blood coagulation disorders were observed in 20/25 children that received AV only at our hospital (incoagulable blood in 17/25). AV early reactions were observed in 20 of these 25 cases (9/9 patients not pretreated and 11/16 patients pretreated with hydrocortisone and histamine H1 and H2 antagonists). There were no significant differences in the frequency of patients with AV early reactions between the groups that were and were not pretreated (Fisher's exact test, p = 0.12). Patients admitted less than and more than 6 h after the bite showed the same risk of developing severe envenoming (Fisher's exact test, p = 1). No children of the first group (< 6 h) showed severe complications whereas 3/6 children admitted more than 6 h post-bite developed acute renal failure. Patients bitten in the legs had a higher risk of developing severe envenoming (Fisher's exact test, p = 0.04). There was a significant association between both total CK and LDH blood enzyme levels and severity (p < 0.001 for CK and p < 0.001 for LDH; Mann-Whitney U test). No deaths were recorded.

Crystallographic studies on molybdopterin-dependent enzymes

Disserta����o para obten����o do Grau de Doutor em Bioqu��mica, Especialidade Bioqu��mica Estrutural